Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
---|---|---|---|---|---|
1 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
JAK1 2件: JAK1, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
2 | Coronavirus disease - COVID-19 💬 51 genes, 94 drugs (DrugBank) and 91 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
3 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
JAK1 3件: JAK1, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
4 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
5 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
6 | Hepatitis B 💬 41 genes, 54 drugs (DrugBank) and 73 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
7 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
JAK1 2件: JAK1, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
8 | Hepatitis C 💬 34 genes, 59 drugs (DrugBank) and 72 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
9 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
JAK1 3件: JAK1, JAK2, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
10 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
11 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
JAK1 2件: JAK1, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
12 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
13 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
JAK1 3件: JAK1, JAK2, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
14 | Influenza A 💬 45 genes, 63 drugs (DrugBank) and 85 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
15 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
16 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
17 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
JAK1 3件: JAK1, JAK2, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
18 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
19 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases |
JAK1 3件: JAK1, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
20 | Measles 💬 40 genes, 44 drugs (DrugBank) and 52 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
21 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
22 | Necroptosis 💬 28 genes, 39 drugs (DrugBank) and 68 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
23 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
JAK1 2件: JAK1, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
24 | NOD-like receptor signaling pathway 💬 30 genes, 42 drugs (DrugBank) and 65 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
25 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
JAK1 2件: JAK1, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
26 | Osteoclast differentiation 💬 36 genes, 71 drugs (DrugBank) and 93 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
27 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
28 | Th1 and Th2 cell differentiation 💬 33 genes, 37 drugs (DrugBank) and 70 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
29 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
30 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|
31 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
JAK1 3件: JAK1, JAK2, TYK2 💬
|
Tofacitinib Tofacitinib 💬
| Tofacitinib | 011 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
|
32 | Toxoplasmosis 💬 25 genes, 39 drugs (DrugBank) and 64 diseases |
TYK2 1件: TYK2 💬
|
Deucravacitinib Deucravacitinib 💬
| Deucravacitinib | 049 3件: 49, 96, 97 💬
|